Industry Notes: Feds Add $3 Billion to Next-Gen COVID Therapy Research Coffers
The government continues to promote COVID-19 vaccination as the best bet to thwart the virus, but the feds also want to study and develop antiviral therapies, too. Read on for the latest news.
Then: In March, President Biden signed the American Rescue Plan Act (ARPA) into law, allocating billions for COVID-related tracing, testing, vaccinations, and research (see Medicare Compliance & Reimbursement, Vol. 47, No. 6).
Now: On June 17, the Department of Health and Human Services (HHS) announced that the feds would be “investing more than $3 billion to accelerate the discovery, development and manufacturing of antiviral medicines...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: